To investigate the association between the PRELP mRNA expression and genomic aberrations, we first analyzed the correlation between PRELP gene expression and somatic mutations and copy number aberrations (CNAs) using a comprehensive genomic dataset of patients with ovarian cancer (see Materials and Methods). The gene discussed is PRELP; the disease is ovarian carcinoma.